Coronary Arteriosclerosis is the buildup of plaque in the arteries of the heart. The causes of Coronary Arteriosclerosis are still being studied, but it may be caused by high blood pressure, high cholesterol, smoking, and diabetes. When the arteries become damaged, blood clots are more likely to form, causing limited blood flow. Coronary Arteriosclerosis might not present any symptoms because of the steady onset, but chest pain is common. Treatments for Coronary Arteriosclerosis include cholesterol medications, angioplasty, and surgery. Lifestyle changes are also very effective when treating Coronary Arteriosclerosis.
Coronary Arteriosclerosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Coronary Arteriosclerosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 2600 products for the study of Coronary Arteriosclerosis that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Coronary Arteriosclerosis is also known as Arteriosclerosis, Coronary, Arteriosclerotic Heart Disease, Ashd, Atherosclerosis Of Coronary Artery, Atherosclerosis, Coronary.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.